Search
Lomedeucitinib
go.drugbank.com/drugs/DB21649InvestigationalLomedeucitinib has a monoisotopic molecular weight of 419.15 Da. … Lomedeucitinib is under investigation in clinical trial NCT05730725 (A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis).
Bimokalner
go.drugbank.com/drugs/DB21717InvestigationalBimokalner has a monoisotopic molecular weight of 355.1 Da. … Bimokalner is under investigation in clinical trial NCT06521190 (ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin).
Bryostatin 1
go.drugbank.com/drugs/DB11752InvestigationalBryostatin 1 has been investigated for the treatment of HIV Infection and Alzheimer's Disease.
Apabetalone
go.drugbank.com/drugs/DB12000InvestigationalApabetalone has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.
Terameprocol
go.drugbank.com/drugs/DB12226InvestigationalTerameprocol has been investigated for the treatment of Brain and Central Nervous System Tumors.
Telenzepine
go.drugbank.com/drugs/DB19508InvestigationalTelenzepine has a monoisotopic molecular weight of 370.15 Da. … Telenzepine is under investigation in clinical trial NCT01155531 (Safety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy Subjects).
Setileuton
go.drugbank.com/drugs/DB19550InvestigationalSetileuton is under investigation in clinical trial NCT00404313 (The Effect of MK0633 in Patients With Chronic Asthma (0633-007)). Setileuton has a monoisotopic molecular weight of 463.12 Da. … The usage of the INN stem '-leuton' in the name indicates that Setileuton is a 5-lipo-oxygenase inhibitor, anti-inflammatory.
Felezonexor
go.drugbank.com/drugs/DB21067InvestigationalFelezonexor has a monoisotopic molecular weight of 419.12 Da. … Felezonexor is under investigation in clinical trial NCT02667873 (A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors).
Icovamenib
go.drugbank.com/drugs/DB21669InvestigationalIcovamenib is under investigation in clinical trial NCT06152042 (Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus). Icovamenib has a monoisotopic molecular weight of 566.28 Da. … The usage of the INN stem '-menib' in the name indicates that Icovamenib is a menin interaction inhibitor.
Methdilazine
go.drugbank.com/drugs/DB00902ApprovedIt is used in the treatment of various dermatoses to relieve pruritus.